Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data

OBJECTIVES: Direct oral anticoagulants (DOACs) were introduced based on randomised controlled trials (RCTs) comparing them to vitamin-K-antagonist (VKA) warfarin. In Germany, almost exclusively phenprocoumon is used as VKA. RCTs with phenprocoumon being absent we analysed the benefits and harms of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Warkentin, Lisette, Klohn, Florian, Deiters, Barthold, Kühlein, Thomas, Hueber, Susann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809214/
https://www.ncbi.nlm.nih.gov/pubmed/36593002
http://dx.doi.org/10.1136/bmjopen-2022-063490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809214/
https://www.ncbi.nlm.nih.gov/pubmed/36593002
http://dx.doi.org/10.1136/bmjopen-2022-063490

Ejemplares similares